A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work

Conditions: Chronic Inflammatory Demyelinating Polyradiculoneuropathy; Polyneuropathy, Inflammatory Demyelinating, Chronic Interventions: Drug: Riliprubart; Drug: Placebo; Drug: Riliprubart; Drug: Placebo Sponsors: Sanofi Not yet recruiting

Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials